Quantumzyme News | finanzen.ch

24.07.25	EQS-News: Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation (EQS Group)
28.04.25	EQS-News: Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent (EQS Group)
23.04.25	EQS-News: Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing (EQS Group)
16.04.25	EQS-News: Quantumzyme Highlights Enzyme Engineering Platform and Ongoing Work in Sustainable Ibuprofen Synthesis (EQS Group)
11.04.25	EQS-News: Quantumzyme: Advancing Enzymatic Innovation for a Sustainable Industrial Future (EQS Group)
08.04.25	EQS-News: Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation (EQS Group)
04.04.25	EQS-News: Quantumzyme Signs MOU With Zummit Africa to Establish a Centre of Excellence in AI for Green Chemistry (EQS Group)
03.04.25	EQS-News: Quantumzyme to Become Fully Reporting SEC Issuer, Unlocking New Growth Potential (EQS Group)
01.04.25	EQS-News: Quantumzyme Highlights Breakthroughs in Enzymatic Catalysis at CCE 2025 (EQS Group)
27.03.25	EQS-News: Quantumzyme Announces Vision to Lead the Future of Sustainable Industrial Biocatalysis (EQS Group)
25.03.25	EQS-News: Quantumzyme Unveils Enhanced Website to Drive Innovation and User Engagement (EQS Group)

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Quantumzyme Corp Registered Shs